Skip to content
healthcare.dev

LEQEMBI

NDC 62856-212, lecanemab, injection, solution, from Eisai Inc..

Product NDC
62856-212
Status
Listed
Labeler
Eisai Inc.
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761269
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62856-212 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LECANEMAB100 mg/mL

Pharmacologic classes

Amyloid Beta-directed Antibody Interactions [MoA]; Amyloid Beta-directed Antibody [EPC]

Package NDCNDC-11Package
62856-212-01628560212011 VIAL, SINGLE-DOSE in 1 CARTON (62856-212-01) / 2 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/9d1ff786-e577-410a-a273-c4d7d0e4e975
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=62856-212

Use it

Look up 62856-212 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62856-212 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62856-212. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.